Form 4 for MGNX MACROGENICS INC
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-15 · accession 0001587514-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-15 | MGNX | Koenig Scott | Dir | M - OptEx | $0.00 | +21.2K | 867.2K | +3% | $0 |
| D | 2026-02-17 | 2026-02-15 | MGNX | Koenig Scott | Dir | M - OptEx | $0.00 | -21.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-15 | M | A | 21,165 | $0.00 | 867,240 | D | — | — | (F1) On February 15, 2023, the reporting person was granted 127,000 restricted stock units. Eighty-four thousand, six hundred seventy (84,670) were vested prior to the reporting person's separation from the company and 21,165 units vested upon his separation on August 13, 2025 in accordance with his Separation Agreement. |
| 2 | Derivative | Restricted Stock Unit | 2026-02-15 | M | D | 21,165 | $0.00 | 0 | D | $0.00 · — to — | 21,165 Common Stock | (F2) Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. (F1) On February 15, 2023, the reporting person was granted 127,000 restricted stock units. Eighty-four thousand, six hundred seventy (84,670) were vested prior to the reporting person's separation from the company and 21,165 units vested upon his separation on August 13, 2025 in accordance with his Separation Agreement. |